Autism Impact Fund is a venture capital fund that focuses on investing in technologies, translational science, and innovative services for autism spectrum disorder (ASD), neurodevelopmental disorders, mental health issues, and complex chronic conditions.

Autism Impact Fund

AIF is a healthcare fund focused on the growing mental health market with a particular emphasis on innovation in ASD (“Autism Spectrum Disorder”) and related conditions (ADD, ADHD, Social Anxiety, GI, etc.). We target market VC returns and invest in scalable businesses that create a better world for individuals with ASD, neurodevelopmental disorders, mental health issues, and other complex chronic conditions.

We extend our thanks and congratulations to Ben and Chris, our interns this summer!
 
They quickly connected with our mission and brought fresh perspectives to our projects. It was a pleasure to witness their growth, and we are excited to see where their journeys lead next.
 
Thank you, Benjamin Cox and Chris Reiter, for your dedication and commitment. We wish you continued success!

We are excited to announce that Christopher Male, AIF's Co-Founder and Managing Partner, will be speaking at #BHT2024! Check out the lineup below, and we hope to see you there ⬇️

Exciting news! AIF is gearing up to join the Behavioral Health Tech conference this November. Kudos to Solome Tibebu and the BHT team for bringing together neurodiversity-focused innovators and providers. #BHT2024

Thank you, Jefferies, for hosting AIF and for the outstanding work the JEFAbilities team is doing!

This Autism Awareness Day, we are grateful for the opportunity to appear on CNBC Squawk Box to talk about Autism Impact Fund, our mission and the 12 amazing portfolio companies we've invested in to-date. Thank you to Joe Kernen, Becky Quick, and Andrew Ross Sorkin for having us on set at Nasdaq.

#autismawarenessday #venturecapital #cnbc #squawkbox #vc #innovation #autism

Last week, AIF was honored to have our Co-founder and Managing Partner, Christopher Male, as one of the distinguished presenters at the Stanford Healthcare Innovation Lab Summit! 

Grateful for the opportunity to contribute groundbreaking insights on autism and utilizing an ecosystem approach. Our discussion highlighted leveraging biomarkers, subtypes, and the venture capital model within an ecosystem to drive innovation and improve outcomes for individuals with autism, neurodevelopmental disorders, and other complex chronic conditions. 

A heartfelt thanks to Stanford for hosting this transformative dialogue! 🚀 #HealthcareInnovation #Stanford #AIFImpact #MHISummit

Great insights from our friends at Ferd Sosiale Entreprenører on our shared portfolio company, auticon

Congratulations to Cortica and the entire team! We are thrilled for everyone involved, especially the ASD community. Onward!

Metric
Company Name	Autism Impact Fund
Symbol
MSH ID	FUND:AUTISMIMPACT
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital
Country	US
Stage
Employee Count	1
Website	autismimpact.fund
LinkedIn	autismimpactfund
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	1.20K
Web Traffic Growth	7.90
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

AUTI

FUND:AUTISMIMPACT

Autism Impact Fund

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue